Lyell
3 known investors
Lyell is a clinical-stage biotech developing next-generation CAR T-cell product candidates intended as one-time treatments for patients with cancer, targeting both hematologic malignancies and solid tumors. The company owns and operates its own manufacturing facility to control its cell therapy supply chain.
BiotechHealthtech
Investors · 3
Frequently asked questions
- What does Lyell do?
- Lyell is a clinical-stage biotech developing next-generation CAR T-cell product candidates intended as one-time treatments for patients with cancer, targeting both hematologic malignancies and solid tumors. The company owns and operates its own manufacturing facility to control its cell therapy supply chain.
- Who are Lyell's investors?
- Lyell's investors include venBio Partners, 8VC, Axial VC.